China Resources Boya Bio pharmaceutical Group Co Ltd (300294) — Capital Reinvestment Ratio
China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a Capital Reinvestment Ratio of 3.33x as of December 2025, meaning it reinvests 3% of its operating cash flow (CN¥36.82 Million) in capital expenditures (CN¥122.46 Million). See China Resources Boya Bio pharmaceutical (300294) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China Resources Boya Bio pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2009–2025)
This chart tracks China Resources Boya Bio pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 15 annual periods. Check China Resources Boya Bio pharmaceutical (300294) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)
Year-by-year Capital Reinvestment Ratio for China Resources Boya Bio pharmaceutical Group Co Ltd from 2009 to 2025. For live market cap and broader valuation context, see China Resources Boya Bio pharmaceutical market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.59x | CN¥116.69 Million | CN¥535.31 Million | ▲ +595.3% |
| 2024 | 0.66x | CN¥299.78 Million | CN¥197.79 Million | ▲ +383.9% |
| 2023 | 0.14x | CN¥641.73 Million | CN¥87.50 Million | ▼ -41.2% |
| 2022 | 0.23x | CN¥596.44 Million | CN¥138.41 Million | ▲ +358.3% |
| 2021 | 0.05x | CN¥1.35 Billion | CN¥68.12 Million | ▼ -74.5% |
| 2020 | 0.20x | CN¥718.58 Million | CN¥142.51 Million | ▼ -93.9% |
| 2018 | 3.26x | CN¥34.90 Million | CN¥113.90 Million | ▲ +116.1% |
| 2016 | 1.51x | CN¥198.76 Million | CN¥300.09 Million | ▲ +39.3% |
| 2015 | 1.08x | CN¥147.02 Million | CN¥159.37 Million | ▲ +175.9% |
| 2014 | 0.39x | CN¥121.88 Million | CN¥47.89 Million | ▲ +6.4% |
| 2013 | 0.37x | CN¥89.11 Million | CN¥32.90 Million | ▲ +39.5% |
| 2012 | 0.26x | CN¥92.36 Million | CN¥24.45 Million | ▲ +18.1% |
| 2011 | 0.22x | CN¥81.53 Million | CN¥18.27 Million | ▼ -84.9% |
| 2010 | 1.48x | CN¥24.77 Million | CN¥36.65 Million | ▲ +38.6% |
| 2009 | 1.07x | CN¥51.88 Million | CN¥55.40 Million | — |